Select Medical Holdings Corporation reaffirms its 2022 business guidance for revenue, which was provided on August 4, 2022. Select Medical continues to expect consolidated revenue to be in the range of $6.25 billion to $6.40 billion for the full year of 2022. Select Medical is also reaffirming its previously issued three-year compound annual growth rate target for revenue only, which is expected to be in the range of 4% to 6% for 2021 through 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.81 USD | -0.41% | +0.30% | +43.87% |
May. 06 | UBS Adjusts Select Medical Price Target to $34 From $31, Maintains Neutral Rating | MT |
May. 06 | Benchmark Adjusts Price Target on Select Medical Holdings to $42 From $39, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.87% | 4.41B | |
+20.09% | 84.56B | |
-27.30% | 72.41B | |
+2.04% | 27.73B | |
-9.00% | 17.75B | |
-1.14% | 17.11B | |
+4.56% | 16.03B | |
+69.72% | 13.07B | |
+6.66% | 12.91B | |
+73.30% | 12.55B |
- Stock Market
- Equities
- SEM Stock
- News Select Medical Holdings Corporation
- Select Medical Holdings Corporation Reaffirms Guidance for Revenue of 2022